Baseline Glycated Hemoglobin Values Predict the Magnitude of Glycemic Improvement in Patients with Type 1 and Type 2 Diabetes: Subgroup Analyses from the DIAMOND Study Program

The DIAMOND study demonstrated that the addition of real-time continuous glucose monitoring (rtCGM) effectively lowers glycated hemoglobin (HbA(1c)) in patients with type 1 (T1D) and type 2 diabetes (T2D), treated with multiple daily injections (MDI). This post hoc analysis investigated whether DIAM...

Descripción completa

Detalles Bibliográficos
Autores principales: Billings, Liana K., Parkin, Christopher G., Price, David
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Mary Ann Liebert, Inc. 2018
Materias:
Brief Reports
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6080123/
https://www.ncbi.nlm.nih.gov/pubmed/30044123
http://dx.doi.org/10.1089/dia.2018.0163

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC6080123/
https://www.ncbi.nlm.nih.gov/pubmed/30044123
http://dx.doi.org/10.1089/dia.2018.0163

Ejemplares similares